Skip to main content

Skin Structures and Soft Tissue Infections

2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
2 programs
2
IclaprimPhase 31 trial
iclaprimPhase 31 trial
Active Trials
NCT02607618Completed613Est. Aug 2017
NCT02600611Completed600Est. Jan 2017
Paratek Pharmaceuticals
1 program
PTK 0796PHASE_31 trial
Active Trials
NCT00876850Withdrawn0Est. Aug 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Biocorpiclaprim
BiocorpIclaprim
Paratek PharmaceuticalsPTK 0796

Clinical Trials (3)

Total enrollment: 1,213 patients across 3 trials

NCT02600611Biocorpiclaprim

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Start: Nov 2015Est. completion: Jan 2017600 patients
Phase 3Completed
NCT02607618BiocorpIclaprim

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Start: Nov 2015Est. completion: Aug 2017613 patients
Phase 3Completed
NCT00876850Paratek PharmaceuticalsPTK 0796

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Start: Jul 2009Est. completion: Aug 20100
Phase 3Withdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.